Background/Objectives: Helicobacter pylori infection and iron and vitamin B 12 deficiencies are widespread in economically disadvantaged populations. There is emerging evidence that H. pylori infection has a negative effect on the absorption of these micronutrients. The aim of this study was to evaluate the effect of H. pylori infection on the efficacy of micronutrient (including iron and vitamin B 12 )-fortified foods supplied for 1 year in marginally nourished children. Subjects/Methods: In all, 543 Indian children, aged 6-10 years, participated in a double-blind, randomized controlled intervention trial, receiving foods fortified with either high (100% Recommended Dietary Allowances (RDA)) or low (15% RDA) amounts of iron, vitamin B 12 and other micronutrients. The presence of H. pylori infection was diagnosed by the 13 C-labeled urea breath test at 11 months after the start of the intervention. Blood hemoglobin, serum ferritin (SF), total body iron and plasma vitamin B 12 were estimated at baseline and 12 months, and differences between these time points were assessed using an independent t-test. Results: Overall, the prevalence of H. pylori infection in this group of children was 79%. Baseline hemoglobin, SF, body iron and vitamin B 12 concentrations were not associated with H. pylori infection. The response to the intervention (either high or low amounts of iron and vitamin B 12 fortification) in terms of change in iron markers and vitamin B 12 status did not differ between children with and without H. pylori infection. Conclusions: This study shows that the presence of H. pylori infection did not affect the efficacy of long-term iron and vitamin B 12 fortification in these marginally nourished children.
Introduction
Helicobacter pylori is a Gram-negative bacterium that colonizes the gastric mucosa in humans (Parsonnet, 1998; Sarker et al., 2004) . Prevalence of H. pylori infection among developing country populations is high, ranging between 50 and 90% (Sarker et al., 1997) , and has been implicated in the etiology of gastric and duodenal ulcer, gastric adenocarcinoma, gastric lymphoma and other morbidities (Marshall and Warren, 1984; Peterson, 1991; Correa, 1992; Uemura et al., 2001; Peek and Blaser, 2002; Suerbaum and Michetti, 2002) . In children, H. pylori infection occurs as early as 3 months into infancy (Thomas et al., 1999) and has been linked with undernutrition and growth faltering (Sullivan et al., 1990; Thomas et al., 2004) . In the absence of antibiotic therapy, H. pylori thrives within the gastric mucosa for decades or even the entire lifetime (Kuipers et al., 2000) . Most infected people tend to be asymptomatic (Dooley et al., 1989) , whereas others commonly suffer from chronic gastritis, not associated with gastro intestinal bleeding or any other specific disease (Hershko and Ronson, 2009) .
In many regions of the world where iron deficiency is common, H. pylori infection is also highly prevalent (Klein et al., 1991; Bardhan, 1997; Torres et al., 2000) . Carefully conducted epidemiological studies have shown a strong association with H. pylori infection and iron deficiency in adults (Milman et al., 1998; Peach et al., 1998) , and in some the infection has also led to the development of iron deficiency anemia (IDA). It has therefore been postulated that H. pylori infection impairs the absorption of iron through altered acid secretion from the gastric mucosa, or through perturbations in the ascorbic acid secretion from the stomach wall by parietal cells, or because of an increased demand for iron (Milman et al., 1998) . Recent evidence of eradication of H. pylori infection with antibiotic therapy, resulting in the reversal of iron deficiency states and an improved response to iron replacement therapy in both children and adults (Dufour et al., 1993; Carnicer et al., 1997) , suggests a strong role of H. pylori in increasing the risk of reduced body iron stores, iron deficiency and IDA (Muhsen and Cohen, 2008) . Similar to iron, the absorption/utilization of vitamin B 12 may also be affected (Kaptan et al., 2000) . Vitamin B 12 absorption is a complex process in which hydrochloric acid and a small protein (intrinsic factor), both produced by the parietal cells of the stomach, have a role. H. pylori-induced cellular changes could affect their physiological function and directly affect absorption of vitamin B 12 .
In poor regions, the diet consumed often fails to meet dietary requirements of the population, and multiple micronutrient deficiencies often coexist (Thankachan et al., 2007) . Fortification of foods with micronutrients is an attractive and sustainable way of delivering additional nutrients to vulnerable population groups. It is important to assess whether H. pylori may blunt the efficacy of such fortification programs because of its influence on the absorption of micronutrients. Therefore, this study aimed to evaluate the effect of H. pylori infection on the absorption of iron and vitamin B 12 from foods fortified with these and other micronutrients, in school children from Bangalore, India.
Subjects and methods
Study site and subjects This study was part of an intervention study (the Children's Health and Mental Performance Influenced by Optimal Nutrition (CHAMPION) study; Muthayya et al., 2009 ) that was carried out among marginally nourished children attending two primary schools in Bangalore, India, over a period of 12 months between November 2005 and March 2007. In brief, that study compared the effect of two different concentrations of a combination of micronutrients and n-3 fatty acids on indicators of growth and cognitive performance (Muthayya et al., 2009) . The study procedures were explained to the parents, and informed written consent from the parents and verbal assent from their children was obtained. The protocol of the study was approved by the ethical committees at St John's National Academy of Health Sciences, Bangalore, India and Wageningen University, The Netherlands. Among a total of 598 children who had been randomized into the intervention trial, 543 children participated in the assessment of H. pylori infection.
Study design
The CHAMPION study (Muthayya et al., 2009 ) used a randomized, double-blind, controlled, 2 Â 2 factorial design, with four parallel treatment groups, providing 100% Recommended Dietary Allowances (RDA; high) or 15% RDA (low) levels of micronutrients and/or high (900 mg a-linolenic acid plus 100 mg docosahexaenoic acid) or low (140 mg a-linolenic acid) levels of n-3 fatty acids as follows:
(1) high micronutrient, high n-3 fatty acid treatment, (2) low micronutrients, high n-3 fatty acid treatment, (3) high micronutrients, low n-3 fatty acid treatment and (4) low micronutrients, low n-3 fatty acid treatment. However, for this study the high and low fatty acid treatment groups were combined with the high and the low micronutrient groups, respectively, to obtain two parallel treatment groups, providing either 100% RDA (high) or 15% RDA (low) concentrations of micronutrients along with high and low levels of fatty acids, respectively. The children in both the treatment groups consumed two fortified products daily: a fruit-flavored snack of extruded wheat flour with a creamy filling inside and a flavored milk powder drink providing 420 kcal and 13.5 g protein per day for a period of 12 months. The high micronutrient and low micronutrient treatment groups provided 18 and 2.7 mg of iron in the form of the ferro-fumarate salt, and 1.8 and 0.27 mg of vitamin B 12 per day, respectively.
Anthropometry
Anthropometric measurements were recorded in duplicate at baseline according to standard techniques (Lohman et al., 1988) . Body weight was recorded to the nearest 0.1 kg using a digital weighing scale (Breuer, Germany), whereas height was recorded to the nearest 0.1 cm using a locally made stadiometer. The weight-for-age and height-for-age Z-scores were computed using the National Center for Health Statistics/World Health Organization growth reference data (WHO, 1995) . Children with weight-for-age and height-for age Z-scores of less than -2 s.d. of this reference median were classified as underweight and stunted, respectively.
H. pylori infection At 11 months into the intervention study, the presence of H. pylori infection was diagnosed by the 13 C-labeled urea breath test. The 13 C-urea breath test is a noninvasive test (Dore et al., 1997; Kehrt et al., 1997; IAEA, 2000) and is administered to children at least 4 h of fasting after breakfast. Two baseline samples (t 0 ) of breath were collected into an empty vacutainer for measurements of 13 CO 2 and following this each child was administered orally 50 mg of 13 C-urea dissolved in 20 ml of water. Immediately after dosing, 100 ml milk containing 5 g beet sugar was administered to delay gastric emptying. Breath samples in duplicate were collected at 30 min (t 30 ) and 45 min (t 45 ) after dosing for isotope ratio mass spectrometry.
Analysis of the breath samples
The breath samples were analyzed for the ratio of 13 CO 2 / 12 CO 2 using an isotope ratio mass spectrometer (Europa Scientific, Crewe, UK). The samples were analyzed by continuous flow mass spectrometry, which incorporated a separation of the sample by gas chromatography followed by isotope ratio measurements. The enrichment of the samples was measured against the enrichment of a standard gas mixture that was earlier calibrated against Peedee Belemnite reference material for carbon. The coefficient of variation of the system was o0.01%. An increase in the 13 CO 2 in breath was detected by the isotope ratio mass spectrometer and expressed as the absolute difference between the 30-and 45-min values and the baseline value. A cutoff value of 3.5 d% above the baseline value was used to classify a positive 13 C-urea breath test result, indicating an H. pylori infection.
Biochemical indicators
At baseline and at 12 months, whole blood was collected from non-fasted children by venipuncture in an EDTA vacutainer. Care was taken to limit the exposure of the samples to light. Hemoglobin concentrations were determined within 4 h of collection using an AcT Diff 2 Counter (Beckman Coulter Inc., Fullerton, CA, USA). The blood was immediately centrifuged (3000 r.p.m., 10 min, 4 1C), and the plasma was stored in 2 ml Eppendorf tubes at À80 1C until analysis. Serum ferritin (SF) was measured by an enzyme immunoassay (Access 2 Beckman Coulter autoanalyser, Brea, CA, USA; Burtis and Ashwood, 1996 ) against an external three-level control material (WHO Standard 80/578; Ramco Laboratories Inc., Houston, TX, USA). Plasma soluble transferrin receptor was measured using an enzyme immunoassay (Ramco Laboratories) with two-level control materials provided by the manufacturer. C-reactive protein was analyzed by a turbidimetric method (Roche Hitachi 902, Indianapolis, IN, USA; Burtis and Ashwood, 1996) . Body iron stores was calculated from the ratio of transferrin receptor and serum ferritin (Cook et al., 2003) . Serum vitamin B 12 was analyzed using a Chemiluminescence System (ACS:180; Bayer Diagnostics, Tarrytown, NY, USA; Miale, 1982 (Allen et al., 2000) .
Statistical analysis
Continuous variables were reported using means and s.d., and categorical variables were reported using numbers and percentages. The w 2 test and an independent t-test were used to assess the effect of intervention between H. pylori-positive and -negative subjects. Data not normally distributed were log transformed for this analysis. Effect of the high versus low micronutrient treatments and their interaction with H. pylori infection status were examined using analysis of covariance with n-3 fatty acid groups as an additional factor in the model to adjust for confounding effects if any. An a-level of o0.05 was considered statistically significant. All analyses were performed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
Results
Of the 598 children randomly allocated into the study, 543 children were assessed for H. pylori infection. The mean age of the children (N ¼ 543) was 8.7 ± 1.7 years. In all, 30% of the children were underweight and 22% were stunted. The prevalence of H. pylori infection was 79%, with an equal proportion of boys and girls being affected. The baseline prevalence of iron deficiency, IDA and vitamin B 12 deficiencies were 31, 7 and 23%, respectively, and did not differ between groups. Among children randomized into the high micronutrient intervention, prevalence of anemia at baseline was, however, significantly higher in the H. pylorinegative children when compared with the H. pylori-positive children.
The baseline profile of the study participants by treatment group and H. pylori status is provided in Table 1 . Baseline hemoglobin, SF, total body iron and vitamin B 12 levels did not differ significantly between H. pylori-infected and noninfected children. No significant differences were observed in the baseline characteristics of age, anthropometry, education level of the mother and family income between children with and without H. pylori infection in the high and low micronutrient treatment groups, respectively.
Discussion
At the end of 12 months of intervention in the CHAMPION study, the change in hemoglobin, SF and vitamin B 12 concentrations to either fortification with high or low doses of iron and vitamin B 12 was similar in children with or without H. pylori infection (P40.05; Table 2 ). In addition, in the subgroup of iron-deficient children in this study, when provided adequate amounts of micronutrients, the subjects without H. pylori infection did not show a better improvement in SF when compared with those with H. pylori infection (data not shown). However, as expected, the increases in hemoglobin, iron and vitamin B 12 concentrations in the high micronutrient groups were significantly larger than the changes in the low micronutrient treatment groups (all Po0.001; Muthayya et al., 2009) .
In this study, the high prevalence (79%) of H. pylori infection did not interfere with the efficacy of iron and vitamin B 12 fortification, as the concentrations of blood hemoglobin, serum iron markers and vitamin B 12 did not differ between the H. pylori-positive and -negative subjects in either the high micronutrient or low micronutrient Median (25-75th percentiles). P-values represent significance of the interaction effect of micronutrient intervention group and H. pylori status using an ANCOVA at 12 months, adjusting for baseline. Values not normally distributed were log transformed for this analysis.
treatment groups. At baseline, H. pylori infection was not associated with either iron or vitamin B 12 status. A significantly higher baseline prevalence of anemia observed in the H. pylori-negative children who were to receive the high micronutrient treatment could have been because of the loss in randomization after regrouping the study subjects as either H. pylori positive or negative. The strength of this study lies in the large representative sample of children in whom a carefully controlled, long-term fortification trial was carried out. To our knowledge, this is the first time that the effect of H. pylori infection has been evaluated within a randomized fortification trial of multiple micronutrients in children over such a period. As H. pylori infection is chronic in nature, the study was designed to both evaluate for H. pylori infection and assess the effect of micronutrient intervention at one instance at the end of the 12-month intervention period. Screening studies carried out earlier in the Bangalore region have also shown a similar high prevalence (82%) of H. pylori infection (Dore et al., 1997) . Furthermore, as the majority of the children were infected, actual differences between the infected and non-infected children may have not reached significance in response to the fortification within the intervention groups. Nevertheless, the findings of this study suggest that among marginally nourished asymptomatic children with H. pylori infection, the absorption of nutrients such as iron and vitamin B 12 may not be affected when assessed over an extended period of time. The high prevalence of H. pylori observed in our study is consistent with the existing body of literature on the high prevalence of H. pylori infection observed among populations from developing countries, and from India Gill et al., 1994; Dore et al., 1997) . In one of these studies on 340 individuals from Mumbai, India, the frequency of H. pylori infection was also found to increase with age. Analysis of sera in these subjects aged 0-4, 5-9 and 10-19 years showed the prevalence of immunoglobulins G and A anti-H. pylori antibodies to be 22 and 56%, 48 and 87% and 58 and 83%, respectively, indicating an early exposure to H. pylori in Indian children (Gill et al., 1994) .
H. pylori is postulated to have a major role in interfering with the normal absorptive process within the gastric lumen by altering acid secretion, reducing vitamin C levels within the gastric juice (Zhang et al., 1998) or by sequestering iron from lactoferrin that is found in gastric mucosa (Dhaenens et al., 1997) . Gastric acid secretion has been shown to significantly improve in iron-deficient, anemic and H. pyloriinfected 2-to 5-year-old Bangladeshi children (Sarker et al., 2004) after the eradication of H. pylori infection through antibiotic therapy. However, in the same study, the use of sensitive stable isotopic techniques to assess iron absorption in the infected children found no significant improvement on iron absorption after H. pylori eradication. Therefore, although it seems that gastric acid secretion may indeed be influenced by H. pylori infection, the degree to which this perturbation occurs is probably very relevant in determining whether or not there would be a decrease in iron absorption.
It is also possible that the bacterium itself has a significant uptake of iron and other nutrients (Milman et al., 1998) . Recent data from Japan suggest that strains of H. pylori derived from patients with IDA have enhanced Fe ion uptake as well as Fe ion-dependent rapid growth when compared with strains isolated from patients without IDA (Yokota et al., 2008 ). In our study, H. pylori infection was not associated with iron or vitamin B 12 status and is in agreement with an earlier study carried out on similar children in India, in whom no relationship between H. pylori infection and rates of anemia or iron deficiency was observed (Mahalanabis et al., 2005) . Similarly, in a study carried out in 1060 adults in New Zealand, there were no significant differences in SF levels between H. pylori-positive and -negative subjects (Collett et al., 1999) . On the other hand, our findings are in contrast to a Korean study carried out in 6-to 12-year-old children in which those found to be seropositive for H. pylori infection had significantly lower SF levels (Seo et al., 2002) .
In terms of interventions, the present study findings also contrast with a previous Indian intervention study providing 20 mg of elemental iron along with vitamin A (Mahalanabis et al., 2005) , in which the hemoglobin of uninfected children improved to a significantly better extent than in infected children. However, this discrepancy could be related to the shorter duration (8 weeks) of the intervention, and it is possible that a steady state of absorption had not yet been achieved, as may have been the case in our long-term study (12 months). Differences observed in results between various studies could also be because of differences in populations, genetics and environmental factors. In addition, the fortified food products administered in our study may have been slightly acidic and the presence of vitamin C in the fortified food may have rendered the iron more soluble and bioavailable. This too may have overcome the problems of iron absorption associated with H. pylori infection. Finally, it is possible that pathological changes to the subjects' gastric structure and acid secretion may have not yet occurred, as all the subjects were also asymptomatic at the time of the study.
Particularly with reference to vitamin B 12 absorption, symptomatic infections with H. pylori have been shown to be important. For example, in patients with dyspepsia, a strong inverse association has been shown to exist between vitamin B 12 levels and H. pylori density, even in those with minimal or no gastric atrophy (Serin et al., 2002) .
Unfortunately, this study has no intermediate values on the iron and vitamin B 12 status of the participants. Additional studies are needed to investigate the kinetics of iron and vitamin B 12 absorption in H. pylori-positive and -negative children. Furthermore, the effect of H. pylori on vitamin C and the effect of vitamin C (either secreted from the stomach wall or provided via the fortified food) on iron absorption remain a topic for further research. In conclusion, this study shows that the presence of H. pylori infection did not affect the efficacy of long-term iron and vitamin B 12 fortification in these marginally nourished Indian children.
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